| INTRODUC TI ON
In Japan, the first in vitro fertilization (IVF) baby was born in 1983, and thereafter, the annual number of assisted reproductive technology (ART) cycles has dramatically increased year by year. Japan has become one of the largest users of ART worldwide in terms of the annual number of treatment cycles done. 1 Records of the characteristics and clinical outcomes of ART are crucial to monitor trends and situations of ART treatment implemented in a country. The Japan Society of Obstetrics and Gynecology TA B L E 1 Trends in numbers of registered cycles, egg retrieval, pregnancy, and neonates according to IVF, ICSI, and frozen-thawed embryo transfer cycles, Japan, 1985 Treatment outcomes for cycles using frozen-thawed oocytes were also reported. The treatment outcomes of registered cycles including pregnancy, miscarriage, live birth, and multiple pregnancy rates according to patients' age are shown in Table 4 . Similarly, the distribution of the pregnancy, live birth, and miscarriage rates according to patients' age is shown in Figure 2 . 
| RE SULTS

| D ISCUSS I ON
Using the current Japanese ART registry system, this study demonstrated that the total number of registered ART cycles was 447 790, and resultant live births were 54 110, accounting for one in 18.1 neonates born in Japan in 2016. These figures are the largest since the registry started. Single ET was performed at rates of more than 80% for both fresh and frozen cycles, resulting in a singleton live birth rate of 96% in total. The number of freeze-all cycles increased, resulting in a reduction in the number of fresh ET cycles. These results represent the latest clinical practice of ART in Japan.
One potential reason for the rising number of ART cycles is the advancing age of patients receiving ART. In the registered cycles, the mean age of registered cycles was 38.1 years (SD = 4.5), which was much higher than the mean age for cycles with live births (35.6 years, SD = 4.0). This age gap between patients receiving ART and patients who gave live birth after ART warrants further investigation. Patients' age is the most important factor determining the probability of a live birth after ART. Since the pregnancy and live birth rates decreased as patients' age increased (Table 4) , the number of ET cycles resulting in a live birth would theoretically exceed that in patients of a younger age. Thus, substantial education of patients regarding the association between age and probabilities for pregnancy in ART is essential.
Single ET was performed at a rate of more than 80% both for fresh and frozen cycles, which is the highest rate in the world. 1 Single ET is one effective way to prevent adverse perinatal outcomes related to multiple births while maintaining a cumulative live birth rate. 4 In 2008, JSOG recommended restricting the number of ETs to one in order to prevent multiple pregnancies, although double ET was allowed for women over 35 years of age or for women who FET, frozen-thawed embryo transfer; SET, single embryo transfer. a Including cycles using frozen-thawed oocyte. b Singleton, twin, triplet and quadruplet pregnancies were defined according to the number of gestational sacs in utero. There was a significant transition to the freeze-all policy (Table 1) .
TA B L E 4
Freeze-all provides an effective treatment option for patients at high risk for ovarian hyper-stimulation syndrome (OHSS), preventing the symptoms and severity becoming worse. 7 A randomized controlled trial (RCT) in China demonstrated that the freeze-all strategy had a significantly decreased risk for adverse outcomes such as OHSS and miscarriage, and a significantly higher rate of live birth among polycystic ovary syndrome (PCOS) patients. 8 Whether the freeze-all strategy would improve ART outcomes among non-PCOS patients remains unresolved. Observational investigations demonstrated that FET cycles resulted in better pregnancy and perinatal outcomes than fresh cycles, 6,9,10 however, two RCTs published in 2018 revealed that the effect of the freeze-all strategy on pregnancy outcomes (ongoing pregnancy and live birth rate) was not different between patients who had the freeze-all strategy and who received fresh ET after oocyte retrievals.
11,12
The strengths of the Japanese ART registry system include its mandatory reporting system and high compliance rate. Patients Reproductive Technologies. 1 Since the Japanese ART registry system has such a significant compliance, the next step for improving the registration system is maintaining the quality of the database. In order to use the registry database for research purposes and for important feedback to participating ART facilities and patients, we need to maintain the integrity of registration, and to assess the validity of the registry, as done by other countries. 13, 14 For example, by maintaining data quality, the United States registry system developed a patients' and clinicians' platform for the prediction of pregnancy and live birth rate (https://www.sart.org/), helpful for patients' education and promoting appropriate informed consent at ART facilities. Thus, the need for ongoing improvements in the registration system for participating ART facilities and patients appears inevitable.
In conclusion, our analysis of the ART registry for 2016 demonstrated that the total number of ART cycles increased and resulted in 54 110 neonates (one in 18.1 neonates in Japan). The patients' age receiving ART was significantly higher than the mean age of patients who had live birth. Single ET was performed at a rate of more than 80%, resulting in a 96% singleton live birth rate. Ongoing investigation is required to determine the effect of the increasing use of freeze-all cycles. These data represent the latest clinical practices of ART in Japan, and further improvements in the registration system in Japan will be important.
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